Extracorporeal shockwave therapy and regenerative medicine and their combination therapy for knee osteoarthritis

Extracorporeal shockwave therapy and regenerative medicine and their combination therapy for knee osteoarthritis - Extracorporeal shockwave therapy and regenerative medicine and their combination therapy for knee osteoarthritis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056999

Enrollment

Registered

2025-02-25

Start date

2025-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed with knee osteoarthritis by X-ray at N Clinic or another hospital, and received intra-articular injections of hyaluronic acid, but the pain did not improve

Exclusion criteria

Exclusion criteria: Patients who have already undergone surgery or other treatments for knee osteoarthritis and those therapeutic effects are likely to be involved, as well as patients with metabolic or infectious diseases such as RA, are excluded from the study.

Design outcomes

Primary

Measure	Time frame
KOOS (Knee injury and Osteoarthritis Outcome Score) data before therapy and at 1 month, 3 months, and 6 months after therapy	—

Secondary

Measure	Time frame
MRI image data before therapy and at 1 month, 3 months, and 6 months after therapy	—

Countries

Japan

Contacts

Public ContactShinya NAKASATO

N clinic medical office

nakasato@n-cli.com0724324976

Outcome results